A-5783 would supplement New Jersey’s law on utilization review for prescription drug benefits. It would require the Commissioner of Banking and Insurance to develop a standard form for network providers to request coverage decisions; its stated goal is to standardize those requests. The bill is introduced and is not law.
No cost information is in the available material.
Bills on related subjects, starting with New Jersey.
The bill would bar health plans, including state and school employee programs, from denying, restricting or delaying drug coverage because a drug received FDA accelerated approval.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
The bill would require health insurers and state employee health-benefit programs to let covered people send and receive plan messages electronically, including claims and enrollment.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pharmacists or their designees would have to notify consumers when dispensing substituted drugs or biological products; existing substitution conditions would remain.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Lawmakers would require health plans and Medicaid to cover 12-month refills of qualifying nonrefrigerated hormone therapy; Medicaid members would pay no cost-sharing.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee